Uncategorized
India Supreme Court determined to protect nation’s generic manufacturing sector
India has an arguably higher bar to get a patent covering a pharmaceutical than any other country. Before 2005, Indian legislation prohibited patenting pharmaceuticals. Only patents to methods of manufacturing a drug could be issued until recently. Under that system, a highly profitable pharmaceutical sector developed in India that continues to this day to supply generic drugs to the world.Last month, the Indian Supreme Court essentially ensured that Indian generic drug companies would continue to thrive when Novartis was denied a patent for Glivec (a cancer drug with the active (Read more...)